Nancy A. Melville
Weight-related COVID-19 severity starts in normal BMI range, especially in young
May 4, 2021
Increases in BMI, beginning in normal ranges, show a linear link to severe COVID-19 outcomes, independent of obesity-related diseases in younger and Black patients.
Metformin treatment again linked to fewer deaths from COVID-19
January 22, 2021
The reduction in mortality among those with diabetes taking metformin prior to COVID-19 diagnosis was significant.
First-of-its kind guideline on lipid monitoring in endocrine diseases
November 6, 2020
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.
Evidence mounts for COVID-19 effects on thyroid gland
August 19, 2020
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid disorders are not at increased risk of contracting SARS-CoV-2.
Large COVID-19 dataset: Kidney injury in >35% of those in hospital
May 20, 2020
The clearest risk factors for the development of AKI were “the need for ventilator support or vasopressor drug treatment.”